| Filed On | Filing |
|---|---|
| 15 May 2025 | SCHEDULE 13G/A |
| 15 May 2025 | SCHEDULE 13G/A |
| 01 May 2025 | 15-12G |
| 23 Apr 2025 | null |
| 23 Apr 2025 |
Form 4: Iconiq Strategic Partners V, L.p., 10% owner and 8 others
Disposed of 9,009,594 shares (Other Transaction) · Disposed of 5,030,000 Common Units of Enfusion Ltd. LLC (Other Transaction) |
| 23 Apr 2025 |
Form 4: Luo Roy, Director
Returned 9,009,594 shares to the issuer · Disposed of 5,030,000 Common Units of Enfusion Ltd. LLC (Disposition to Issuer) |
| 21 Apr 2025 |
Form 4: Pawar Neal, Chief Operating Officer
Returned 1,217,308 shares to the issuer |
| 21 Apr 2025 |
Form 4: Herring Bradley, Chief Financial Officer
Returned 324,689 shares to the issuer |
| 21 Apr 2025 |
Form 4: Movchan Oleg, Director and 1 other
Returned 1,783,665 shares to the issuer |
| 21 Apr 2025 |
Form 4: Leibowitz Lawrence E, Director
Returned 175,572 shares to the issuer |
| 21 Apr 2025 |
Form 4: Hauser Jan, Director
Returned 57,925 shares to the issuer |
| 21 Apr 2025 |
Form 4: Gutowski Valeria, Chief Accounting Officer
Returned 47,622 shares to the issuer |
| 21 Apr 2025 |
Form 4: Campobasso Matthew, General Counsel
Returned 70,946 shares to the issuer |
| 21 Apr 2025 |
Form 4: Somers Deirdre, Director
Returned 41,675 shares to the issuer |
| 21 Apr 2025 |
Form 4: DeRose Kathleen, Director
Returned 60,716 shares to the issuer |
| 21 Apr 2025 |
Form 4: Spellacy Michael, Director
Returned 56,810 shares to the issuer |
| 21 Apr 2025 |
Form 4: Bastone Bronwen, Chief People Officer
Returned 213,051 shares to the issuer · Disposed of 10,000 Stock Option (Right to Buy) (Disposition to Issuer) |
| 21 Apr 2025 |
Form 4: Bernstein Bradford E, Director and 1 other
Returned 32,440,463 shares to the issuer |
| 21 Apr 2025 | null |
| 21 Apr 2025 | null |
Loading...
